Catatonic Schizophrenia

 Catatonic Schizophrenia is a severe clinical presentation of schizophrenia characterised primarily by profound motor, behavioural, and communication disturbances. Unlike standard presentations of schizophrenia where hallucinations and delusions dominate the clinical picture, catatonia manifests as severe abnormalities in voluntary movement, ranging from complete immobility (stupor) to hyperactive, non-goal-directed agitation (excited catatonia).

Key Clinical Manifestations

Catatonia affects muscle control, body posture, and behavioural initiation:

• Stuporous Symptoms:

  • Mutism: Total or near-total absence of speech.

  • Stupor: Unresponsiveness to environmental stimuli despite preserved consciousness.

  • Rigidity: Rigid posture that strongly resists external manipulation or attempts to be moved.

  • Negativism: Active resistance or motivation-less opposition to instructions or physical movement.

  • Waxy Flexibility (Cerea Flexibilitas): A state where an individual's limbs remain in whatever position they are manually placed by an examiner.

• Excited Symptoms:

  • Purposeless Agitation: Rapid, chaotic, or repetitive movements (e.g., pacing, arm flapping) driven by internal dysfunction rather than external events.

• Echo Phenomena & Stereotypies:

  • Echolalia: Automatic repetition of words spoken by another person.

  • Echopraxia: Automatic imitation of another person's physical movements.

  • Stereotypy & Posturing: Maintenance of bizarre, uncomfortable postures or repetitive non-goal-directed movements.

Neurobiology & Etiology

Catatonic features stem from disrupted circuit dynamics across specific brain structures, particularly involving motor-planning networks and neurotransmitter pathways.

• Brain Structures Involved: Disruption occurs within the basal ganglia (involved in motor control and movement initiation) and the frontal lobes (involved in motor planning and executive function).

• Neurotransmitter Imbalances:

  • GABA Systems: Hypofunction of gamma-aminobutyric acid type A ($GABA_A$) receptors in the orbitofrontal cortex leads to loss of motor inhibition.

  • Dopamine & Glutamate: Imbalances in dopamine transmission along motor pathways contribute to both motor blockades (rigidity/stupor) and hyperactive motor discharges.

Modern Diagnostic Criteria (DSM-5)

In earlier diagnostic systems (DSM-IV), Catatonic Schizophrenia was designated as a distinct clinical subtype. In the DSM-5, catatonia is categorised as a specifier associated with schizophrenia or other mental/medical conditions (e.g., Schizophrenia with Catatonia). Diagnosis requires at least 3 out of 12 core diagnostic signs:

1. Stupor

2. Catalepsy

3. Waxy flexibility

4. Mutism

5. Negativism

6. Posturing

7. Mannerisms

8. Stereotypy

9. Agitation (not influenced by external stimuli)

10. Grimacing

11. Echolalia

12. Echopraxia

Management Strategies

Treating catatonia requires rapid clinical response to prevent secondary physical complications such as severe dehydration, deep vein thrombosis (DVT), pulmonary embolism, or pressure ulcers.

Treatment Modality	Mechanism of Action	Clinical Application
Benzodiazepines (e.g., Lorazepam)	Enhances $GABA_A$ receptor activity, restoring inhibitory control over motor circuits.	First-line intervention. High-dose IV/oral lorazepam often produces rapid resolution of motor signs within hours.
Electroconvulsive Therapy (ECT)	Induces controlled therapeutic seizures under general anaesthesia to reset circuit activity.	Second-line / Emergency treatment. Highly effective when benzodiazepines fail or when rapid response is required for life-threatening catatonia.
Antipsychotics	D2 receptor blockade for underlying psychotic symptoms.	Used with caution during acute catatonia; high-potency typical antipsychotics can precipitate or worsen catatonic symptoms and increase the risk of Neuroleptic Malignant Syndrome (NMS).